68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical
- Conditions
- Interventions
- First Posted Date
- 2021-04-05
- Last Posted Date
- 2021-12-03
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 10
- Registration Number
- NCT04831307
- Locations
- 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada
PRecision Oncology Evidence Development in Cancer Treatment - Clinical: PREDiCTc
- First Posted Date
- 2021-03-24
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 30
- Registration Number
- NCT04814095
- Locations
- 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada
A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer
- Conditions
- Interventions
- First Posted Date
- 2021-03-08
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 244
- Registration Number
- NCT04787289
- Locations
- 🇨🇦
Abbotsford Centre, BC Cancer Agency, Abbotsford, British Columbia, Canada
🇨🇦BC Cancer - Vancouver, Vancouver, British Columbia, Canada
Detection of Covid-19 by Volatile Organic Compounds in Exhaled Breath
- Conditions
- First Posted Date
- 2021-01-19
- Last Posted Date
- 2021-01-22
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 1000
- Registration Number
- NCT04714333
- Locations
- 🇨🇦
BC Cancer Research Centre, Vancouver, British Columbia, Canada
🇨🇦British Columbia Research Centre, Vancouver, British Columbia, Canada
Tailored Adjuvant Therapy in POLE-mutated and p53-wildtype Early Stage Endometrial Cancer
- Conditions
- First Posted Date
- 2021-01-12
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 42
- Registration Number
- NCT04705649
- Locations
- 🇨🇦
BC Cancer - Vancouver Centre, Vancouver, British Columbia, Canada
5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)
- First Posted Date
- 2020-10-30
- Last Posted Date
- 2023-12-18
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 168
- Registration Number
- NCT04610372
- Locations
- 🇨🇦
Fraser Valley Cancer Center, Surrey, British Columbia, Canada
🇨🇦Vancouver Cancer Center, Vancouver, British Columbia, Canada
🇨🇦Vancouver Island Cancer Center, Victoria, British Columbia, Canada
CARA Treatment Pilot Study for Breast Positioning
- Conditions
- Interventions
- First Posted Date
- 2020-09-10
- Last Posted Date
- 2020-09-10
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 20
- Registration Number
- NCT04543851
- Locations
- 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada
Dynamic Whole Body PET/ MRI
- First Posted Date
- 2020-08-03
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 30
- Registration Number
- NCT04495959
- Locations
- 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada
[68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer
- First Posted Date
- 2020-07-23
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 1574
- Registration Number
- NCT04484701
- Locations
- 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity
- First Posted Date
- 2020-02-17
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 200
- Registration Number
- NCT04273061
- Locations
- 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada
🇨🇦University Health Network / Princess Margaret Cancer Centre, Toronto, Ontario, Canada